SCYX - SCYNEXIS INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 1.54

Open

$ 1.54

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.54 - $ 1.57

52 Week Range

$ 1.35 - $ 3.87

Volume

157,721

Average Volume

Market Cap

74.52M

Beta (5Y Monthly)

$ 1.33

PE Ratio (TTM)

$ 1.11

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-28-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-31-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-15-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-29-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-17-2021	03-31-2021	10-Q
13	03-29-2021	12-31-2020	10-K
14	11-06-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-11-2020	03-31-2020	10-Q
17	03-11-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	03-14-2019	12-31-2018	10-K
22	11-13-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	03-13-2018	12-31-2017	10-K
26	11-07-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-08-2017	03-31-2017	10-Q
29	03-13-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-08-2016	06-30-2016	10-Q
32	05-09-2016	03-31-2016	10-Q
33	03-07-2016	12-31-2015	10-K
34	11-13-2015	09-30-2015	10-Q
35	08-19-2015	06-30-2015	10-Q
36	05-15-2015	03-31-2015	10-Q
37	03-30-2015	12-31-2014	10-K
38	11-13-2014	09-30-2014	10-Q
39	08-13-2014	06-30-2014	10-Q
40	06-16-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 12:31:45

Cantor Fitzgerald analyst Louise Chen reiterates SCYNEXIS (NASDAQ:SCYX) with a Overweight.

SCYNEXIS Q4 EPS $(0.39) Misses $(0.20) Est...
03/29/2024 03:36:25

SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.20) by...

SCYNEXIS Presented Preclinical Data On Sec...
01/29/2024 22:18:02

In vivo data demonstrated response rate for oral SCY-247 similar to current standard of care, intravenous Liposomal Amphoterici...

5-value-stocks-to-watch-in-the-healthcare-sector

5 Value Stocks To Watch In The Healthcare ...
01/29/2024 14:44:11

A Look Into Healthcare Sector Value Stocks
01/08/2024 14:44:03

SCYNEXIS To Present Preclinical Data On Se...
01/05/2024 13:36:59

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-trea...

why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Why Resources Connection Shares Are Tradin...
01/04/2024 12:59:32

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
01/03/2024 13:05:55

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
01/02/2024 21:31:10

SCYNEXIS Entered Into Binding MoU For Amen...
01/02/2024 21:13:34

-SEC Filing Granted for all indications, in all countries other than Greater China and certain other countries already licensed...

SCYNEXIS Q3 EPS $(0.04) Vs $(0.62) Last Ye...
11/13/2023 22:22:49

SCYNEXIS Presents New Preclinical Data On ...
10/24/2023 12:17:09

The analyses were presented by Mahmoud Ghannoum, Ph.D, Professor and Director Center for Medical Mycology, Case Western Reserve...

SCYNEXIS To Present Preclinical Data On Se...
10/16/2023 12:27:06

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-trea...

SCYNEXIS Recalls BREXAFEMME Nationwide Ove...
09/28/2023 06:34:07

gold-moves-lower-transcode-therapeutics-shares-surge

Gold Moves Lower; TransCode Therapeutics S...
09/25/2023 18:43:02

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. Th...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
09/25/2023 17:31:08

why-brainstorm-cell-therapeutics-shares-are-trading-lower-by-33-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Brainstorm Cell Therapeutics Shares Ar...
09/25/2023 17:04:42

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical glib...

Nasdaq Turns Higher; SCYNEXIS Shares Plunge
09/25/2023 16:12:45

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded do...

why-are-antifungal-focused-scynexis-stock-plunging-today

Why Are Antifungal Focused Scynexis Stock ...
09/25/2023 15:53:10

Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga

us-stocks-open-lower-chicago-fed-index-falls-in-august

U.S. Stocks Open Lower; Chicago Fed Index ...
09/25/2023 13:58:16

U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the mar...